Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The cost-effectiveness of rituximab in non-Hodgkin's lymphomaChristopher Knight, Fiona Maciver
Journal of Medical Education and Curricular Development|June 7, 2021
Supporting Medical Student Mental Health during COVID-19: Strategies Implemented for an Accelerated Curriculum Medical CampusSonal Chandratre, Christopher Knight, Lisa Dodson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 12, 2013
Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysisSukhvinder Johal, Stephen Ralston, Christopher Knight
Structural Dynamics (Melville, N.Y.)|August 9, 2021
Fluorescence intensity correlation imaging with high spatial resolution and elemental contrast using intense x-ray pulsesPhay J Ho, Christopher Knight, Linda Young
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Economic Modeling Considerations for Rare DiseasesIsobel Pearson, Ben Rothwell, Andrew Olaye, et al.
Pharmacoeconomics - Open|June 28, 2021
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UKT Alexander Russell-Smith, James Brockbank, Carla Mamolo, et al.
The Journal of Physical Chemistry Letters|May 26, 2017
Molecular Origin of the Vibrational Structure of Ice IhDaniel R Moberg, Shelby C Straight, Christopher Knight, et al.
Journal of Health & Pollution|June 9, 2020
Mercury Exposure Associated with Use of Skin Lightening Products in JamaicaPhylicia Ricketts, Christopher Knight, Andre Gordon, et al.
The Journal of Physical Chemistry. A|June 28, 2019
Anharmonic Rovibrational Partition Functions at High Temperatures: Tests of Reduced-Dimensional Models for Systems with up to Three Fluxional ModesAhren W Jasper, Lawrence B Harding, Christopher Knight, et al.
Pageof 4